BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9581897)

  • 21. WHO statement on hormonal contraception and bone health.
    d'Arcangues C
    Contraception; 2006 May; 73(5):443-4. PubMed ID: 16627029
    [No Abstract]   [Full Text] [Related]  

  • 22. Medroxyprogesterone acetate-induced secondary adrenal insufficiency.
    Dux S; Bishara J; Marom D; Blum I; Pitlik S
    Ann Pharmacother; 1998 Jan; 32(1):134. PubMed ID: 9475840
    [No Abstract]   [Full Text] [Related]  

  • 23. Medroxyprogesterone acetate (Depo-Provera) and bone mineral density loss.
    Wooltorton E
    CMAJ; 2005 Mar; 172(6):746. PubMed ID: 15743913
    [No Abstract]   [Full Text] [Related]  

  • 24. [Characteristics of differentiation of mouse vaginal epithelium in normal state and in the process of blastomogenesis].
    Vol'fson NI; Sokolovskiĭ RM
    Arkh Patol; 1966; 28(11):45-50. PubMed ID: 6002051
    [No Abstract]   [Full Text] [Related]  

  • 25. Women seek alternatives to hormone replacement therapy.
    Altern Ther Health Med; 2002; 8(5):27. PubMed ID: 12233798
    [No Abstract]   [Full Text] [Related]  

  • 26. Studying the effects of reproductive hormones and bacterial vaginosis on the glycome of lavage samples from the cervicovaginal cavity.
    Wang L; Koppolu S; Chappell C; Moncla BJ; Hillier SL; Mahal LK
    PLoS One; 2015; 10(5):e0127021. PubMed ID: 25993513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An estradiol mitotic rate inhibiting effect in the Müllerian epithelium in neonatal mice.
    Forsberg JG
    J Exp Zool; 1970 Nov; 175(3):369-74. PubMed ID: 5529519
    [No Abstract]   [Full Text] [Related]  

  • 28. Prevention by progesterone of cervicovaginal lesions in neonatally estrogenized BALB/c mice.
    Jones LA; Verjan RP; Mills KT; Bern HA
    Cancer Lett; 1984 Jun; 23(2):123-8. PubMed ID: 6744239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Depo-Provera -- proving its innocence.
    Choudhury IR
    Indian Med Trib; 1994 Jul; 2(11):5. PubMed ID: 12179187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment with an ovulation-inhibiting hormone combination with lower progestin component. Cytologic and histologic studies].
    Breinl H; Dehnhard F
    Med Klin; 1970 Jan; 65(5):195-9. PubMed ID: 5413357
    [No Abstract]   [Full Text] [Related]  

  • 31. Long-acting progestogen contraceptives.
    Power J; Guillebaud J
    Practitioner; 2002 May; 246(1634):332, 335-9, 341. PubMed ID: 12043350
    [No Abstract]   [Full Text] [Related]  

  • 32. [Cytological aspect of cervico-vaginal smears from patients treated by oral contraceptives].
    Siebert S; Jobert ME; Besançon D
    Rev Fr Gynecol Obstet; 1972; 67(8):489-504. PubMed ID: 4645506
    [No Abstract]   [Full Text] [Related]  

  • 33. Injectable contraception.
    International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
    IPPF Med Bull; 1980 Dec; 14(6):1-3. PubMed ID: 12310087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In favor of continued use of depot medroxyprogesterone acetate (DMPA, Depo-Provera) in adolescents.
    Cromer B
    J Pediatr Adolesc Gynecol; 2005 Jun; 18(3):183-7. PubMed ID: 15970253
    [No Abstract]   [Full Text] [Related]  

  • 35. Roles of p63 in the diethylstilbestrol-induced cervicovaginal adenosis.
    Kurita T; Mills AA; Cunha GR
    Development; 2004 Apr; 131(7):1639-49. PubMed ID: 14998922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hormonal and cytopathological changes in vaginal and cervical smears from women undergoing chemotherapy for extragenital malignant diseases.
    Schachter A; Kopmar A; Avram E; Gorodeski IG; Segal A
    Acta Obstet Gynecol Scand; 1983; 62(6):621-4. PubMed ID: 6670467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of estriol on the female uterus and vagina].
    Dapunt O; Födisch HJ
    Geburtshilfe Frauenheilkd; 1968 Dec; 28(12):1142-57. PubMed ID: 5711412
    [No Abstract]   [Full Text] [Related]  

  • 38. Combination hormone replacement therapy and dementia.
    Wooltorton E
    CMAJ; 2003 Jul; 169(2):133. PubMed ID: 12874164
    [No Abstract]   [Full Text] [Related]  

  • 39. Depot medroxyprogesterone acetate (DMPA, Depo-Provera) in adolescents: what is next after the FDA black box warning.
    Omar H; Kives S
    J Pediatr Adolesc Gynecol; 2005 Jun; 18(3):183. PubMed ID: 15970252
    [No Abstract]   [Full Text] [Related]  

  • 40. Progestogen-only contraceptives and cancer risk.
    La Vecchia C; Franceschi S
    Eur J Cancer Prev; 2002 Apr; 11(2):113-5. PubMed ID: 11984127
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.